NCT00369798View on ClinicalTrials.gov

Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 2, 2006

Primary Completion Date

June 16, 2016

Study Completion Date

October 12, 2016

Conditions
Major Depressive DisorderHealthy
Interventions
PROCEDURE

PET scan

DRUG

Rolipram

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH

NCT00369798 - Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed Patients | Biotech Hunter | Biotech Hunter